Immunoassays of human trefoil factors 1 and 2: Measured on serum from patients with inflammatory bowel disease

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 64, Issue 2, 2004, Pages 146-156

  Vestergaard, E M ^a,e   Brynskov, J ^b   Ejskjaer K ^a   Clausen, J T ^c   Thim, L ^c   Nexo E ^a   Poulsen, S S ^d  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c NOVO NORDISK A S   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e VIBORG HOSPITAL   (Denmark)

Author keywords

ELISA; Inflammatory bowel disease; Trefoil factors

Indexed keywords

MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; TREFOIL PEPTIDE;

ADULT; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOOD INTAKE; HUMAN; IMMUNOASSAY; MALE; MEDICAL ASSESSMENT; MENSTRUAL CYCLE; PRIORITY JOURNAL; REDUCTION; REFERENCE VALUE;

ADOLESCENT; ADULT; AGED; AGING; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH; HUMANS; IMMUNOASSAY; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; MUCINS; MUSCLE PROTEINS; PEPTIDES; PROTEINS; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR PROTEINS;

LOTUS; ORYCTOLAGUS CUNICULUS;

EID: 1842854757     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510410001176     Document Type: Article

References (36)

1. Masiakowski P, Breathnach R, Bloch J, Gannon F, Krust A, Chambon P. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res 1982; 10: 7895-903.
2. Jakowlew SB, Breathnach R, Jeltsch JM, Masiakowski P, Chambon P. Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7. Nucleic Acids Res 1984; 12: 2861-78.
3. Prud'homme JF, Fridlansky F, Le Cunff M, Atger, M, Mercier-Bodart C, Pichon MF, Milgrom E. Cloning of a gene expressed in human breast cancer and regulated by estrogen in MCF-7 cells. DNA 1985; 4: 11-21.
4. Jørgensen KH, Thim L, Jacobsen HE. Pancreatic spasmolytic polypeptide (PSP): I. Preparation and initial chemical characterization of a new polypeptide from porcine pancreas. Regul Pept 1982; 3: 207-19.
5. Thim L, Jørgensen KH, Jørgensen KD. Pancreatic spasmolytic polypeptide (PSP): II. Radioimmunological determination of PSP in porcine tissues, plasma and pancreatic juice. Regul Pept 1982; 3: 221-30.
6. Suemori S, Lynch-Devaney K, Podolsky DK. Identification and characterization of rat intestinal trefoil factor: tissue-and cell-specific member of the trefoil protein family. Proc Natl Acad Sci USA 1991; 88: 11017-21.
7. Hauser F, Poulsom R, Chinery R, Rogers LA, Hanby AM, Wright NA, Hoffmann W. hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. Proc Natl Acad Sci USA 1993; 90: 6961-5.
8. Podolsky DK, Lynch-Devaney K, Stow JL, Oates P, Murgue B, De Beaumont M, Sands BE, Mahida YR. Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion. J Biol Chem 1993; 268: 6694-702.
9. Thim L. A new family of growth factor-like peptides. "Trefoil" disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins). FEBS Lett 1989; 250: 85-90.
10. Thim L. Trefoil peptides: from structure to function. Cell Mol Life Sci 1997; 53: 888-903.
11. Thim L, Wöldike HF, Nielsen PF, Christensen M, Lynch-Devaney K, Podolsky DK. Characterization of human and rat intestinal trefoil factor produced in yeast. Biochemistry 1995: 34: 4757-64.
12. Chadwick MP, Westley BR, May FE. Homo-dimerization and hetero-oligomerization of the single-domain trefoil protein pNR-2/pS2 through cysteine 58. Biochem J 1997; 327: 117-23.
13. Newton JL, Allen A, Westley BR, May FEB. The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach. Gut 2000; 46: 312-20.
14. Kannan R, Tomasetto C, Staub A, Bossenmeyer-Pourie C, Thim L, Nielsen PF, Rio MC. Human pS2/trefoil factor 1: production and characterization in Pichia pastoris. Protein Expr Purif 2001; 21: 92-8.
15. Rio MC, Bellocq JP, Daniel JY, Tomasetto C, Lathe R, Chenard MP, Batzenschlager A, Chambon P. Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science 1988; 241(4866): 705-8.
16. Rio MC, Chenard MP, Wolf C, Marcellin L, Tomasetto C, Lathe R, Bellocq JP, Chambon P. Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastroenterology 1991; 100: 375-9.
17. Wright NA, Poulsom R, Stamp G, Van Noorden S, Sarraf C, Elia G, Ahnen D, Jeffery R, Longcroft J, Pike C, Rio MC, Chambon P. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology 1993; 104: 12-20.
18. Babyatsky MW, de Beaumont M, Thim L, Podolsky DK. Oral trefoil peptides protect against ethanol-induced and indomethacin-induced gastric injury in rats. Gastroenterology 1996; 110: 489-97.
19. Mashimo H, Wu DC, Podolsky DK, Fishman MC. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 1996; 274(5285): 262-5.
20. Poulsen SS, Thulesen J, Christensen L, Nexø E, Thim L. Metabolism of oral trefoil factor 2 (TFF2) and the effect of oral and parenteral TFF2 on gastric and duodenal ulcer healing in the rat. Gut 1999; 45: 516-22.
21. Marchbank T, Cox HM, Goodlad RA, Giraud AS, Moss SF, Poulsom R, Wright NA, Jankowski J, Playford RJ. Effect of ectopic expression of rat trefoil factor family 3 (intestinal trefoil factor) in the jejunum of transgenic mice. J Biol Chem 2001; 276: 24088-96.
22. Wright NA, Pike C, Elia G. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature 1990; 343(6253): 82-5.
23. Longman RJ, Douthwaite J, Sylvester PA, Poulsom R, Corfield AP, Thomas MG, Wright NA. Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa. Gut 2000; 47: 792-800.
24. May FE, Westley BR. Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells. J Pathol 1997; 182: 404-13.
25. Vestergaard EM, Poulsen SS, Grønbæk H, Larsen R, Nielsen AM, Ejskjær K, Clausen JT, Thim L, Nexø E. Development and evaluation of an ELISA for human trefoil factor 3. Clin Chem 2002; 48: 1689-95.
26. Langholz E, Munkholm P, Davidsen M, Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994; 107: 3-11.
27. Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence. Scand J Gastroenterol 1992; 27: 609-14.
28. Thim L, Norris K, Norris F, Nielsen PF, Bjørn SE, Christensen M, Petersen J. Purification and characterization of the trefoil peptide human spasmolytic polypeptide (hSP) produced in yeast. FEBS Lett 1993; 318: 345-52.
29. Kohler G, Milstein C. Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur J Immunol 1976; 6: 511-9.
30. Taggart RT, Samloff IM. Stable antibody-producing murine hybridomas. Science 1983; 219(4589): 1228-30.
31. Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989; 27: 409-37.
32. Solberg H. Establishment and use of reference values. In: Tietz N, editor. Textbook of clinical chemistry. Philadelphia: WB Saunders; 1986. p. 356-86.
33. Semple JI, Newton JL, Westley BR, May FEB. Dramatic diurnal variation in the concentration of the human trefoil peptide TFF2 in gastric juice. Gut 2001; 48: 648-55.
34. Duclos B, Rio MC, Reimund JM, Chamouard P, Baumann R, Chambon P, Weill JP. Increased pS2 secretion in serum of Crohn's disease (CD) patients. Gastroenterology 1991; 100 Suppl: A520 (Abstract).
35. Alison MR, Chinery R, Poulsom R, Ashwood P, Longcroft JM, Wright NA. Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomach. J Pathol 1995; 175: 405-14.
36. Thim L, Madsen F, Poulsen SS. Effect of trefoil factors on the viscoelastic properties of mucus gels. Eur J Clin Invest 2002; 32: 519-27.